|
| Home : Araim's Cibinetide Enhances Endothelial Stem Cell Mediated Vascular Regeneration for Treatment of Retinal Ischemia |
|
Apr 01
2019 |
Araim's Cibinetide Enhances Endothelial Stem Cell Mediated Vascular Regeneration for Treatment of Retinal Ischemia |
|
TARRYTOWN, N.Y., April 1, 2019 /PRNewswire/ -- Cibinetide, the lead compound of Araim Pharmaceuticals, Inc., a clinical stage biotechnology company pioneering the development of innate repair receptor (IRR) activator platform technology, has recently been shown to improve the efficacy of... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/araims-cibinetide-enhances-endothelial-stem-cell-mediated-vascular-regeneration-for-treatment-of-retinal-ischemia-300821512.html |
| |
|
Related News
|
» Greenlight Energy enters into $5,000,000 Credit Facility with V3 Commodities Group
» ISLE 2019 zog führende Größen der LED-Branche an, die hunderte neue Display-Produkte vorstellten
|
|
|
